Esperion Therapeutics, Inc. (ESPR)

USD 1.09

(10.77%)

Revenue Summary of Esperion Therapeutics, Inc.

  • Esperion Therapeutics, Inc.'s latest annual revenue in 2023 was 116.33 Million USD , up 54.14% from previous year.
  • Esperion Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 73.83 Million USD , down -46.39% from previous quarter.
  • Esperion Therapeutics, Inc. reported a annual revenue of 75.47 Million USD in annual revenue 2022, down -3.79% from previous year.
  • Esperion Therapeutics, Inc. reported a annual revenue of 78.44 Million USD in annual revenue 2021, down -65.52% from previous year.
  • Esperion Therapeutics, Inc. reported a quarterly revenue of 137.73 Million USD for 2024 Q1, up 327.09% from previous quarter.
  • Esperion Therapeutics, Inc. reported a quarterly revenue of 116.33 Million USD for 2023 FY, up 54.14% from previous quarter.

Annual Revenue Chart of Esperion Therapeutics, Inc. (2023 - 1999)

Historical Annual Revenue of Esperion Therapeutics, Inc. (2023 - 1999)

Year Revenue Revenue Growth
2023 116.33 Million USD 54.14%
2022 75.47 Million USD -3.79%
2021 78.44 Million USD -65.52%
2020 227.54 Million USD 53.37%
2019 148.36 Million USD -19.57%
2018 184.47 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 4.97 Billion USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 2000.00 USD 0.0%
1999 - USD 0.0%

Peer Revenue Comparison of Esperion Therapeutics, Inc.

Name Revenue Revenue Difference
Theratechnologies Inc. 81.76 Million USD -42.28%
Safety Shot Inc 202.67 Thousand USD -57300.701%
Cosmos Health Inc. 53.37 Million USD -117.948%
Cronos Group Inc. 88.84 Million USD -30.946%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 73.724%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Organogenesis Holdings Inc. 433.14 Million USD 73.142%
Universe Pharmaceuticals INC 32.3 Million USD -260.07%
ProPhase Labs, Inc. 44.38 Million USD -162.108%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -813.498%
Dynavax Technologies Corporation 232.28 Million USD 49.917%
Radius Health, Inc. 2.88 Billion USD 95.964%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -5932.366%
Alvotech 91.43 Million USD -27.233%
Sunshine Biopharma, Inc. 24.09 Million USD -382.858%
Alpha Teknova, Inc. 36.68 Million USD -217.125%
Intra-Cellular Therapies, Inc. 464.37 Million USD 74.948%
SCYNEXIS, Inc. 140.14 Million USD 16.988%
Harrow Health, Inc. 130.19 Million USD 10.645%
Biofrontera Inc. 34.07 Million USD -241.446%
DURECT Corporation 8.54 Million USD -1260.95%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 80.851%
ANI Pharmaceuticals, Inc. 486.81 Million USD 76.103%
OptiNose, Inc. 70.98 Million USD -63.881%
RedHill Biopharma Ltd. 6.51 Million USD -1686.134%
Aquestive Therapeutics, Inc. 50.58 Million USD -129.986%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -194.125%
SIGA Technologies, Inc. 139.91 Million USD 16.855%
Lifecore Biomedical, Inc. 128.26 Million USD 9.299%
Shineco, Inc. 9.8 Million USD -1086.857%
Phibro Animal Health Corporation 1.01 Billion USD 88.569%
Procaps Group S.A. 409.92 Million USD 71.62%
TherapeuticsMD, Inc. 1.3 Million USD -8835.023%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 15.42 Billion USD 99.246%
Sunshine Biopharma, Inc. 24.09 Million USD -382.858%
Rockwell Medical, Inc. 83.61 Million USD -39.136%
Incannex Healthcare Limited 12 Thousand USD -969350.0%
Aytu BioPharma, Inc. 81 Million USD -43.619%
Tilray Brands, Inc. 788.94 Million USD 85.254%
Collegium Pharmaceutical, Inc. 566.76 Million USD 79.474%
PetIQ, Inc. 1.1 Billion USD 89.443%
Silver Spike Investment Corp. 11.72 Million USD -892.43%
Neurocrine Biosciences, Inc. 1.88 Billion USD 93.835%
Journey Medical Corporation 79.18 Million USD -46.922%
Alimera Sciences, Inc. 80.75 Million USD -44.06%
Petros Pharmaceuticals, Inc. 5.82 Million USD -1898.046%
Assertio Holdings, Inc. 152.06 Million USD 23.499%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Embecta Corp. 1.12 Billion USD 89.62%
Cyclo Therapeutics, Inc. 1.07 Million USD -10707.642%
Procaps Group, S.A. 409.92 Million USD 71.62%
PainReform Ltd. - USD -Infinity%
Avadel Pharmaceuticals plc 27.96 Million USD -316.028%
Hempacco Co., Inc. 4.04 Million USD -2775.542%
Talphera, Inc. 651 Thousand USD -17770.046%
Pacira BioSciences, Inc. 674.97 Million USD 82.765%
Alvotech 91.43 Million USD -27.233%
Lantheus Holdings, Inc. 1.29 Billion USD 91.027%
Kamada Ltd. 144.75 Million USD 19.636%
Indivior PLC 1.09 Billion USD 89.356%
Currenc Group, Inc. 53.25 Million USD -118.446%
Evoke Pharma, Inc. 5.18 Million USD -2145.557%
Flora Growth Corp. 76.07 Million USD -52.928%
Cyclo Therapeutics, Inc. 1.07 Million USD -10707.642%
Evolus, Inc. 202.08 Million USD 42.433%
HUTCHMED (China) Limited 837.99 Million USD 86.118%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 81.947%
Akanda Corp. 2.16 Million USD -5285.704%